Annotation (Toggle Detail/Summary View) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene-Chemical Interaction Annotations
Gene-Chemical Interaction AnnotationsTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:736155 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PAK3 mRNA | CTD | PMID:19933214 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:736155 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PAK3 mRNA | CTD | PMID:21570461 | 2,3-dimethoxynaphthalene-1,4-dione | increases expression | EXP | | 6480464 | 2,3-dimethoxy-1,4-naphthoquinone results in increased expression of PAK3 mRNA | CTD | PMID:19031421 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of PAK3 mRNA | CTD | PMID:21934132 | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in decreased expression of PAK3 mRNA | CTD | PMID:15894607 | arsenite(3-) | decreases expression | ISO | RGD:736155 | 6480464 | arsenite results in decreased expression of PAK3 mRNA | CTD | PMID:18191166 | asbestos | decreases expression | EXP | | 6480464 | Asbestos results in decreased expression of PAK3 mRNA | CTD | PMID:22076105 | benzo[a]pyrene | decreases expression | ISO | RGD:736155 | 6480464 | Benzo(a)pyrene results in decreased expression of PAK3 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | increases expression | ISO | RGD:736155 | 6480464 | Benzo(a)pyrene results in increased expression of PAK3 mRNA | CTD | PMID:22228805 | bis(2-chloroethyl) sulfide | decreases expression | ISO | RGD:736155 | 6480464 | Mustard Gas results in decreased expression of PAK3 mRNA | CTD | PMID:18955075 | C60 fullerene | decreases expression | ISO | RGD:3251 | 6480464 | fullerene C60 results in decreased expression of PAK3 mRNA | CTD | PMID:19167457 | cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of PAK3 mRNA | CTD | PMID:19031421 | chlorpyrifos | decreases expression | ISO | RGD:3251 | 6480464 | Chlorpyrifos results in decreased expression of PAK3 mRNA | CTD | PMID:18668222 | cisplatin | increases expression | ISO | RGD:736155 | 6480464 | Cisplatin results in increased expression of PAK3 mRNA | CTD | PMID:21151649 | copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of PAK3 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | RGD:736155 | 6480464 | Cyclosporine results in decreased expression of PAK3 mRNA | CTD | PMID:19770486 | D-glucose | decreases expression | ISO | RGD:736155 | 6480464 | Glucose results in decreased expression of PAK3 mRNA | CTD | PMID:17178593 | Delta(9)-tetrahydrocannabinol | decreases expression | ISO | RGD:3251 | 6480464 | Tetrahydrocannabinol results in decreased expression of PAK3 mRNA | CTD | PMID:17578508 | diarsenic trioxide | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in decreased expression of PAK3 mRNA | CTD | PMID:15894607 | glucose | decreases expression | ISO | RGD:736155 | 6480464 | Glucose results in decreased expression of PAK3 mRNA | CTD | PMID:17178593 | kainic acid | decreases expression | ISO | RGD:3251 | 6480464 | Kainic Acid results in decreased expression of PAK3 mRNA | CTD | PMID:19700661 | levonorgestrel | multiple interactions | EXP | | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PAK3 mRNA | CTD | PMID:19074003 | methoxychlor | increases methylation | ISO | RGD:3251 | 6480464 | Methoxychlor results in increased methylation of PAK3 gene | CTD | PMID:23303685 | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of PAK3 mRNA | CTD | PMID:19031421 | ochratoxin A | increases expression | ISO | RGD:3251 | 6480464 | ochratoxin A results in increased expression of PAK3 mRNA | CTD | PMID:19717638 | phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of PAK3 mRNA | CTD | PMID:19031421 | tetrachloroethene | increases expression | EXP | | 6480464 | Tetrachloroethylene results in increased expression of PAK3 mRNA | CTD | PMID:19031421 | thioacetamide | increases expression | ISO | RGD:3251 | 6480464 | Thioacetamide results in increased expression of PAK3 mRNA | CTD | PMID:22659510 | titanium dioxide | increases expression | ISO | RGD:736155 | 6480464 | titanium dioxide results in increased expression of PAK3 mRNA | CTD | PMID:23409001 | troglitazone | decreases expression | ISO | RGD:3251 | 6480464 | troglitazone results in decreased expression of PAK3 mRNA | CTD | PMID:21515302 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene Ontology Annotations
Molecular Pathway Annotations| External Database Links | |
| KEGG Pathway | Axon guidance |
| ErbB signaling pathway | |
| Focal adhesion | |
| Regulation of actin cytoskeleton | |
| Renal cell carcinoma | |
| T cell receptor signaling pathway | |
| Pathway Interaction Database | Regulation of p38-alpha and p38-beta (PID:200066) |
Disease Annotations
Gene-Chemical Interaction Annotations
|
|
|
Gene Ontology Annotations
|
|
|
|
|
|
Molecular Pathway Annotations
|
|
| External Database Links | |
| KEGG Pathway | Axon guidance |
| ErbB signaling pathway | |
| Focal adhesion | |
| Regulation of actin cytoskeleton | |
| Renal cell carcinoma | |
| T cell receptor signaling pathway | |
| Pathway Interaction Database | Regulation of p38-alpha and p38-beta (PID:200066) |
References - curated
References - uncurated
RGD Disease Portals| PAK3 has been annotated in the following RGD Disease Portals. |
|||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
Comparative Map Data| PAK3 (Homo sapiens) |
|
|||||||||||||||||||||||||||||||||||
| Pak3 (Mus musculus) |
|
|||||||||||||||||||||||||||||||||||
| Pak3 (Rattus norvegicus) |
|
Position Markers| DXS7481 |
|
||||||||||||||||||||||||||||||||||||||||
| AL031080 |
|
||||||||||||||||||||||||||||||||||||||||
| DXS7037E |
|
||||||||||||||||||||||||||||||||||||||||
| AL032605 |
|
||||||||||||||||||||||||||||||||||||||||
| DXS6944E |
|
||||||||||||||||||||||||||||||||||||||||
| U39738 |
|
||||||||||||||||||||||||||||||||||||||||
| G66773 |
|
||||||||||||||||||||||||||||||||||||||||
| RH66644 |
|
||||||||||||||||||||||||||||||||||||||||
| PAK3_2323 |
|
||||||||||||||||||||||||||||||||||||||||
| AFM317wb9 |
|
||||||||||||||||||||||||||||||||||||||||
| SHGC-32136 |
|
||||||||||||||||||||||||||||||||||||||||
| DXS8346 |
|
||||||||||||||||||||||||||||||||||||||||
| DCX |
|
QTLs in Region (Human Genome Assembly GRCh37)| The following QTLs overlap with this region. | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer | ![]() | Gviewer |
Nucleotide Sequences| RefSeq Acc Id: | NM_001128166 | ||||||||||||||||||||
| RefSeq Status: | REVIEWED | ||||||||||||||||||||
| Type: | CODING | ||||||||||||||||||||
| Protein Acc Id: | NP_001121638 | ||||||||||||||||||||
| Peptide Label: | isoform a | ||||||||||||||||||||
| Position: |
|
| RefSeq Acc Id: | NM_001128167 | ||||||||||||||||||||
| RefSeq Status: | REVIEWED | ||||||||||||||||||||
| Type: | CODING | ||||||||||||||||||||
| Protein Acc Id: | NP_001121639 | ||||||||||||||||||||
| Peptide Label: | isoform a | ||||||||||||||||||||
| Position: |
|
| RefSeq Acc Id: | NM_002578 | |||||||||||||||||||||||||
| RefSeq Status: | REVIEWED | |||||||||||||||||||||||||
| Type: | CODING | |||||||||||||||||||||||||
| Protein Acc Id: | NP_002569 | |||||||||||||||||||||||||
| Peptide Label: | isoform a | |||||||||||||||||||||||||
| Position: |
|
| RefSeq Acc Id: | NM_001128168 | ||||||||||||||||||||
| RefSeq Status: | REVIEWED | ||||||||||||||||||||
| Type: | CODING | ||||||||||||||||||||
| Protein Acc Id: | NP_001121640 | ||||||||||||||||||||
| Peptide Label: | isoform b | ||||||||||||||||||||
| Position: |
|
| RefSeq Acc Id: | NM_001128172 | ||||||||||||||||||||
| RefSeq Status: | REVIEWED | ||||||||||||||||||||
| Type: | CODING | ||||||||||||||||||||
| Protein Acc Id: | NP_001121644 | ||||||||||||||||||||
| Peptide Label: | isoform c | ||||||||||||||||||||
| Position: |
|
| RefSeq Acc Id: | NM_001128173 | ||||||||||||||||||||
| RefSeq Status: | REVIEWED | ||||||||||||||||||||
| Type: | CODING | ||||||||||||||||||||
| Protein Acc Id: | NP_001121645 | ||||||||||||||||||||
| Peptide Label: | isoform d | ||||||||||||||||||||
| Position: |
|
Protein Sequences
Promoters| RGD ID: | 6809105 | ||||||||||
| Promoter ID: | HG_KWN:67762 | ||||||||||
| Type: | CpG-Island | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | MPROMDB | ||||||||||
| Tissues & Cell Lines: | Lymphoblastoid | ||||||||||
| Transcripts: | ENST00000262836, ENST00000360648, ENST00000372010, NM_002578, OTTHUMT00000057920 | ||||||||||
| Position: |
|
External Database Links| Database | Acc Id | Source(s) |
| COSMIC | PAK3 | COSMIC |
| Ensembl Genes | ENSG00000077264 | ENTREZGENE |
| Ensembl Protein | ENSP00000262836 | ENTREZGENE |
| ENSP00000353864 | ENTREZGENE | |
| ENSP00000361077 | ENTREZGENE | |
| ENSP00000389172 | ENTREZGENE | |
| ENSP00000401982 | ENTREZGENE | |
| ENSP00000410853 | ENTREZGENE | |
| Ensembl Transcript | ENST00000262836 | ENTREZGENE |
| ENST00000360648 | ENTREZGENE | |
| ENST00000372007 | ENTREZGENE | |
| ENST00000417227 | ENTREZGENE | |
| ENST00000425146 | ENTREZGENE | |
| ENST00000446737 | ENTREZGENE | |
| Entrez Gene | 5063 | ENTREZGENE |
| Gene3D-CATH | 10.10 | UniProtKB/Swiss-Prot |
| Germonline | ENSG00000077264 | |
| HGNC ID | 8592 | ENTREZGENE |
| HomoloGene Group ID | 55664 | ENTREZGENE |
| HPRD ID | 02142 | ENTREZGENE |
| InterPro | Kinase-like_dom | UniProtKB/Swiss-Prot |
| PAK_box_Rho-bd | UniProtKB/Swiss-Prot | |
| Prot_kinase_cat_dom | UniProtKB/Swiss-Prot | |
| Protein_kinase_ATP_BS | UniProtKB/Swiss-Prot | |
| Ser/Thr_kinase_AS | UniProtKB/Swiss-Prot | |
| Ser/Thr_kinase_dom | UniProtKB/Swiss-Prot | |
| KEGG Report | hsa:5063 | ENTREZGENE, UniProtKB/Swiss-Prot |
| OMIM | 300142 | OMIM |
| 300558 | OMIM | |
| Pfam | PBD | UniProtKB/Swiss-Prot |
| Pkinase | UniProtKB/Swiss-Prot | |
| PharmGKB | PA32919 | PharmGKB |
| PROSITE | CRIB | UniProtKB/Swiss-Prot |
| PROTEIN_KINASE_ATP | UniProtKB/Swiss-Prot | |
| PROTEIN_KINASE_DOM | UniProtKB/Swiss-Prot | |
| PROTEIN_KINASE_ST | UniProtKB/Swiss-Prot | |
| SMART | PBD | UniProtKB/Swiss-Prot |
| S_TKc | UniProtKB/Swiss-Prot | |
| Superfamily-SCOP | Kinase_like | UniProtKB/Swiss-Prot |
| UniGene | Hs.656789 | ENTREZGENE |
| UniProt | B1AKS5_HUMAN | UniProtKB/TrEMBL |
| B2RCU6_HUMAN | UniProtKB/TrEMBL | |
| PAK3_HUMAN | UniProtKB/Swiss-Prot |
Nomenclature History| Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
|---|---|---|---|---|---|---|---|
| 2011-08-16 | PAK3 | p21 protein (Cdc42/Rac)-activated kinase 3 | PAK3 | p21 protein (Cdc42/Rac)-activated kinase 3 | Symbol and/or name change | 39860 | APPROVED |
| More on PAK3 | |||
![]() |
Entrez Gene | ||
![]() |
Ensembl Gene | ||
|
|
||
![]() |
HGNC Report | ||
![]() |
NCBI Map Viewer | ||
![]() |
Vista | ||
![]() |
Vista + UCSC | ||
| RGD Object Information | |
| RGD ID: | 731864 |
| Created: | 2004-01-12 |
| Species: | Homo sapiens |
| Last Modified: | 2013-05-28 |
| Status: | ACTIVE |
© Bioinformatics Program, HMGC at the Medical College of Wisconsin
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.




